Carl C. Schimanski

1.4k total citations
28 papers, 1.1k citations indexed

About

Carl C. Schimanski is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Carl C. Schimanski has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Immunology and 5 papers in Surgery. Recurrent topics in Carl C. Schimanski's work include Chemokine receptors and signaling (10 papers), Immunotherapy and Immune Responses (10 papers) and Colorectal Cancer Treatments and Studies (8 papers). Carl C. Schimanski is often cited by papers focused on Chemokine receptors and signaling (10 papers), Immunotherapy and Immune Responses (10 papers) and Colorectal Cancer Treatments and Studies (8 papers). Carl C. Schimanski collaborates with scholars based in Germany, Switzerland and France. Carl C. Schimanski's co-authors include Peter R. Galle, Markus Moehler, Martin R. Berger, Ines Gockel, T Junginger, Nektaria Simiantonaki, Stefan Biesterfeld, Caren Jayasinghe, U. Gönner and Hauke Lang and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.

In The Last Decade

Carl C. Schimanski

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl C. Schimanski Germany	18	718	348	309	173	150	28	1.1k
Qiu-Zhong Pan China	22	552 0.8×	505 1.5×	442 1.4×	125 0.7×	120 0.8×	26	1.1k
Jing-Jing Zhao China	25	813 1.1×	786 2.3×	448 1.4×	154 0.9×	141 0.9×	37	1.5k
Qi-Jing Wang China	18	683 1.0×	673 1.9×	337 1.1×	93 0.5×	93 0.6×	26	1.1k
Mónica Musteanu Spain	14	552 0.8×	121 0.3×	415 1.3×	149 0.9×	107 0.7×	32	972
C Lu Japan	8	658 0.9×	197 0.6×	1.0k 3.4×	167 1.0×	118 0.8×	11	1.4k
Mark Gimbel United States	12	680 0.9×	127 0.4×	378 1.2×	159 0.9×	125 0.8×	17	1.0k
Laurence Cooke United States	19	505 0.7×	215 0.6×	532 1.7×	207 1.2×	56 0.4×	39	1.1k
Severino Montemurro Italy	16	353 0.5×	201 0.6×	404 1.3×	148 0.9×	192 1.3×	35	901
Antonella Licchetta Italy	16	490 0.7×	282 0.8×	211 0.7×	131 0.8×	92 0.6×	22	830
Makoto Ichiba Japan	8	786 1.1×	420 1.2×	504 1.6×	178 1.0×	108 0.7×	11	1.2k

Countries citing papers authored by Carl C. Schimanski

Since Specialization

Citations

This map shows the geographic impact of Carl C. Schimanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl C. Schimanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl C. Schimanski more than expected).

Fields of papers citing papers by Carl C. Schimanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl C. Schimanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl C. Schimanski. The network helps show where Carl C. Schimanski may publish in the future.

Co-authorship network of co-authors of Carl C. Schimanski

This figure shows the co-authorship network connecting the top 25 collaborators of Carl C. Schimanski. A scholar is included among the top collaborators of Carl C. Schimanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl C. Schimanski. Carl C. Schimanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Graf, Claudine, Marc A. Becker, Martin R. Berger, et al.. (2016). Analysis of the expression of SDF-1 splicing variants in human colorectal cancer and normal mucosa tissues. Oncology Letters. 11(3). 1873–1878. 8 indexed citations

Schmidtmann, Irene, Thomas Thomaidis, Peter R. Galle, et al.. (2016). Last line therapy with sorafenib in colorectal cancer: A retrospective analysis. World Journal of Gastroenterology. 22(23). 5400–5400. 7 indexed citations

Moehler, Markus, Daniela E. Aust, Heike I. Grabsch, et al.. (2016). Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives. European Journal of Cancer. 59. 160–170. 55 indexed citations

Thomaidis, Thomas, Arndt Weinmann, Martin F. Sprinzl, et al.. (2013). Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patients. International Journal of Clinical Oncology. 19(2). 288–296. 11 indexed citations

Wehler, Thomas, Annett Maderer, Claudine Graf, et al.. (2012). Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy. International Journal of Colorectal Disease. 28(3). 385–398. 23 indexed citations

Schimanski, Carl C., Markus Moehler, George Sgourakis, et al.. (2011). VEGF‐D Correlates with Metastatic Disease in Gastric Cancer Patients Undergoing Surgery. World Journal of Surgery. 35(5). 1010–1016. 17 indexed citations

Zimmermann, Tim, Markus Moehler, Ines Gockel, et al.. (2010). Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration. International Journal of Colorectal Disease. 25(4). 417–424. 26 indexed citations

Schimanski, Carl C., Markus Moehler, Tim Zimmermann, et al.. (2010). Nachweis hepatischer Mikrometastasen. DMW - Deutsche Medizinische Wochenschrift. 135(21). 1078–1082. 1 indexed citations

Lyros, Orestis, Annett Mueller, Florian H. Heidel, et al.. (2009). Analysis of anti‐proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi‐receptor tyrosine kinase pathways. International Journal of Cancer. 127(5). 1197–1208. 30 indexed citations

10.

Moehler, Markus, Martin F. Sprinzl, Carl C. Schimanski, et al.. (2009). Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients. World Journal of Gastroenterology. 15(4). 449–449. 34 indexed citations

11.

Schimanski, Carl C., Peter R. Galle, & Markus Moehler. (2008). Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors. World Journal of Gastroenterology. 14(30). 4721–4721. 42 indexed citations

12.

Cindy, S., Claudine Graf, Stefan Biesterfeld, et al.. (2008). Strong Expression of Chemokine ReceptorCXCR4 by Renal Cell Carcinoma Correlates with Advanced Disease. Journal of Oncology. 2008. 1–6. 32 indexed citations

13.

Sprinzl, Martin F., Carl C. Schimanski, Markus Moehler, et al.. (2006). Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report. BMC Cancer. 6(1). 190–190. 25 indexed citations

14.

Gockel, Ines, Carl C. Schimanski, Christian Heinrich, et al.. (2006). Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma. BMC Cancer. 6(1). 290–290. 51 indexed citations

15.

Waldner, Maximilian J., Carl C. Schimanski, F. Bittinger, et al.. (2006). Massive gastrointestinale Blutung eines 28-jährigen Patienten mit intestinalem Befall eines Morbus Behçet. Zeitschrift für Gastroenterologie. 44(10). 1047–1051. 1 indexed citations

16.

Schimanski, Carl C., Ines Gockel, Wernér E.G. Müller, et al.. (2006). Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. British Journal of Cancer. 95(2). 210–217. 141 indexed citations

17.

Schimanski, Carl C., Anja‐Katrin Bosserhoff, Frauke Bataille, et al.. (2005). Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene. 24(19). 3100–3109. 114 indexed citations

18.

Schimanski, Carl C., Jürgen Burg, Markus Moehler, et al.. (2004). Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure. Journal of Hepatology. 41(1). 67–74. 30 indexed citations

19.

Theobald, Matthias, Edite Antunes Ferreira, Georg Heß, et al.. (2004). Control Of Organ Transplant-Associated Graft-versus-Host Disease By Activated Host Lymphocyte Infusions. Transplantation. 78(12). 1774–1779. 26 indexed citations

20.

Schimanski, Carl C., et al.. (1999). Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.. PubMed. 59(20). 5169–75. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact